6 research outputs found
Limitation of the excessive extracellular matrix turnover is a major determinant of the beneficial effect of spironolactone on survival in patients with CHF: Insights from the RALES trial
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/106131/1/ejhf80350-5.pd